Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.
about
New Trends in Radionuclide Myocardial Perfusion ImagingComparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imagingRegadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledgeTracking a therapeutic response: how reliable are serial measurements of LV perfusion and function?Nuclear cardiology: 2014 innovations and developmentsAccelerated dual-contrast first-pass perfusion MRI of the mouse heart: development and application to diet-induced obese miceEffect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study.Safety and tolerability of regadenoson CMR.Predictors and Diagnostic Significance of the Adenosine Related Side Effects on Myocardial Perfusion SPECT/CT Imaging.Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging.A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease.The prognostic value of regadenoson myocardial perfusion imaging.A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary diseaseEANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revisionQuantitative analysis of perfusion studies: strengths and pitfallsComparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy.The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study.Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysisAutomated Quantitative Nuclear Cardiology MethodsHyperemic stress myocardial perfusion cardiovascular magnetic resonance in mice at 3 Tesla: initial experience and validation against microspheres.Detection of coronary artery disease with perfusion stress echocardiography using a novel ultrasound imaging agent: two Phase 3 international trials in comparison with radionuclide perfusion imaging.Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance.Concordance and diagnostic accuracy of vasodilator stress cardiac MRI and 320-detector row coronary CTA.Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy.Safety and tolerability of intravenous regadenoson in healthy subjects: A randomized, repeat-dose, placebo-controlled study.Assessment of global myocardial perfusion reserve using cardiovascular magnetic resonance of coronary sinus flow at 3 Tesla.Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients.Selective adenosine agonists and myocardial perfusion imaging.Targeting adenosine receptors in the development of cardiovascular therapeutics.Regadenoson: a focused update.Regadenoson for myocardial perfusion scintigraphy.Recent trends in nuclear cardiology practiceSerious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.Regadenoson stress for myocardial perfusion imaging.Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration.Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review.Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations.Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging.Feasibility, safety and accuracy of regadenoson-atropine (REGAT) stress echocardiography for the diagnosis of coronary artery disease: an angiographic correlative study.Safety and tolerability of regadenoson in 514 SPECT MPI patients with and without coronary artery disease and submaximal exercise heart rate response.
P2860
Q26749265-C2A3F42B-527F-49A5-8027-C2E8465A77A4Q26827495-90FE68A9-1931-453E-917E-EB0DE9255585Q26829779-6B236BFE-DC0F-4372-8C21-C690587559AEQ27005931-340F1462-7203-4120-B431-F5CCBF060C53Q28081835-47CF4B9B-5FF0-4D66-96C3-DBC5C90FBD0CQ30360543-96337A5A-3C4B-46F1-850A-BDCAC9D2D9A3Q33561287-0655F5EC-1B83-48DB-B86B-BC638B605662Q33767994-F2219B65-E76F-458D-947E-142C284109A4Q34883899-BFED1490-3B93-41F9-A3CC-0D6E23E9B212Q35243117-FEA02731-E9AD-4A71-BA2B-AC87A5B43978Q35904476-1A03B331-436A-4C86-AC38-293A1F2C6368Q35956486-0C917029-F54B-467E-8500-2A25D142DF0DQ36091069-B716C77A-F46F-4999-AE2B-64A1EB7C8900Q36109226-0DC893EE-BEBA-4F74-9276-1B1645CAB3EAQ36142720-82D6CB2A-6D3F-453B-950A-BF126EF691A3Q36227434-03343A0B-9CD7-409F-92AF-C6865F221E80Q36296064-8C8A1229-4DC8-434A-81DB-B932E4771239Q36601740-8CB9F0E2-C43A-4FB2-BFE0-7ADB4C53C6CFQ36927242-2F448815-3AD7-4C5C-B0F8-F833B5196E70Q37112884-8729B7E5-B647-469B-8E4F-F84136B1FBE7Q37364994-9C6F60BC-AA06-4E43-897E-CBAFA4AD16CBQ37425510-18C1C439-6C2D-4FC5-A746-FC7A538CB39BQ37526226-5D405068-3021-4714-A970-7A00DBA9869DQ37554933-2396B310-AE3E-4C0C-A7A6-C1CB6AE0F568Q37596745-F3154207-78BA-46FD-B76D-EA3E49D64D43Q37688871-935DD915-37B0-4EEF-8052-FC896A6134C9Q37882493-1E64B7BB-20DF-4FC1-BE49-79C231977144Q37963279-61A86A72-1332-49BD-B76C-3ECEA377B189Q37990558-90FA92E1-A9E6-44E0-A9C9-7988399C14CBQ38066403-0ACE6EF8-42FC-490A-AD0E-FAF91C10144EQ38089891-B257AFDE-C7D5-470C-A336-163FD11327F5Q38134745-CF174605-42EE-4A6A-ACCC-DE39C10BE18CQ38480969-A9B97B98-D79A-481C-93E8-96954226A74BQ38660349-217132EB-20DD-426D-AB83-615DCD8F1099Q38691042-0FEBF416-3B82-407D-A9CE-94D7E5D51843Q38707736-D03A69AC-267B-44F4-ADED-680EE0AD3591Q38741610-0E190366-E977-4F1D-8D7D-FF302813580AQ38802421-B972E186-7C83-435E-A7B1-4840DE7DED92Q39264143-81436293-8F3B-4A50-B460-1C6CCD673F95Q39508932-0DD767D6-B27B-48F1-88F6-8F21861D94ED
P2860
Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Effects of age, gender, obesit ...... ted ADVANCE-MPI trial results.
@en
Effects of age, gender, obesit ...... ted ADVANCE-MPI trial results.
@nl
type
label
Effects of age, gender, obesit ...... ted ADVANCE-MPI trial results.
@en
Effects of age, gender, obesit ...... ted ADVANCE-MPI trial results.
@nl
prefLabel
Effects of age, gender, obesit ...... ted ADVANCE-MPI trial results.
@en
Effects of age, gender, obesit ...... ted ADVANCE-MPI trial results.
@nl
P2093
P1476
Effects of age, gender, obesit ...... ted ADVANCE-MPI trial results.
@en
P2093
ADVANCE-MPI Trial Investigators
Ami E Iskandrian
Manuel D Cerqueira
Patricia Nguyen
Peter Staehr
S Richard Underwood
P304
P356
10.1016/J.JCMG.2008.02.003
P577
2008-05-01T00:00:00Z